FDA Adverse Event Injury Summary report: N

EVO/EVO+ VISIAN IMPLANTABLE COLLAMER LENS

MDR report key: 25104887 · Received May 6, 2026

Report

Report Number
2023826-2026-00778
Event Type
Injury
Date Received
May 6, 2026
Date of Event
April 29, 2026
Report Date
May 6, 2026
Manufacturer
STAAR SURGICAL COMPANY
Product Code
MTA
UDI-DI
00840311300877
PMA / PMN Number
P030016
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

H6: INVESTIGATION TYPE 4110: A LENS WORK ORDER SEARCH WAS PERFORMED. NO ADDITIONAL SIMILAR COMPLAINT TYPE EVENTS WITHIN ASSOCIATED LOTS WERE FOUND. H11-MANUFACTURER NARRATIVE: IRITIS IS AN INFLAMMATORY CONDITION WHICH IS COMMON AFTER INTRA-OCULAR SURGERY, HOWEVER THIS IS USUALLY MILD AND DOES NOT REQUIRE ANY ADDITIONAL INTERVENTIONS BEYOND THE STANDARD POST-OP REGIMEN. IN SOME CASES, THE DEGREE OF INFLAMMATION MAY BE MORE SEVERE AND REQUIRE EXTENDED STEROID TREATMENT. PROCEDURAL FACTORS INCLUDING EXCESSIVE SURGICAL MANIPULATION AND THE USE OF PRO-INFLAMMATORY SUBSTANCES IN THE EYE MAY HAVE CONTRIBUTED TO THE EVENT. MECHANICAL INSULT TO THE IRIS CAN RESULT IN A PROLONGED OR STRONGER INFLAMMATORY RESPONSE. AN EXACT CAUSE COULD NOT BE DETERMINED AS THE EVENT COULD BE MULTIFACTORIAL IN NATURE INCLUDING PATIENT AND/OR PROCEDURE RELATED FACTORS. CLAIM # (B)(4).

Description of Event or Problem · 0

A FACILITY REPRESENTATIVE REPORTED THAT FOLLOWING AN IMPLANTABLE COLLAMER LENS (ICL) IMPLANTATION PROCEDURE, THE PATIENT EXPERIENCED UVEITIS / IRITIS, SIGNIFICANT REDUCTION OF ENDOTHELIAL CELL COUNT AND MYDRIASIS. NO DIAGNOSTIC CULTURES WERE PERFORMED. TREATMENT WAS PERFORMED BUT PROBLEM WAS NOT RESOLVED. LENS REMAINS IMPLANTED. CAUSE OF THE EVENT WAS REPORTED AS UNKNOWN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
171555 EVO/EVO+ VISIAN IMPLANTABLE COLLAMER LENS PHAKIC INTRAOCULAR LENS MTA STAAR SURGICAL COMPANY VICM5 13.2 (-7.00) 00840311300877

Patients

Seq Age Sex Outcome Treatment
1